Innovita Biological Technology Co. Ltd. A Cash Flow Quality Index
Innovita Biological Technology Co. Ltd. A cash flow quality index. Innovita Biological Technology Co. Ltd. A (688253) has a Cash Flow Quality Index of 1.34x as of December 2025. Operating cash flow of CN¥193.13 Million exceeds net income of CN¥144.47 Million, indicating high earnings quality where cash backs reported profits. See 688253 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Innovita Biological Technology Co. Ltd. A (2020–2025)
Cash flow quality index of Innovita Biological Technology Co. Ltd. A from 2020 to 2025. Historical Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 688253 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Innovita Biological Technology Co. Ltd. A Cash Flow Quality Index by Year (2020–2025)
Innovita Biological Technology Co. Ltd. A cash flow quality index by year from 2020 to 2025. Year-by-year earnings quality comparison for Innovita Biological Technology Co. Ltd. A. For the full cash flow conversion analysis, see cash flow conversion of Innovita Biological Technology Co. Ltd. .
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | CN¥193.13 Million | CN¥144.47 Million | ▲ +7.5% |
| 2024 | 1.24x | CN¥305.46 Million | CN¥245.69 Million | ▼ -16.8% |
| 2023 | 1.49x | CN¥259.85 Million | CN¥173.95 Million | ▲ +78.0% |
| 2022 | 0.84x | CN¥126.43 Million | CN¥150.68 Million | ▼ -5.1% |
| 2021 | 0.88x | CN¥106.27 Million | CN¥120.25 Million | ▼ -21.4% |
| 2020 | 1.12x | CN¥639.82 Million | CN¥569.00 Million | — |